1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1 |
Follow OM Pharma SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OM 85 to Prevent Respiratory Infections in Older At Risk Patients Bacterial Lysate, Placebo - Respiratory Tract Infections (RTI) | Phase 4 | Recruiting | Campus Bio-Medico University | 360 | 2025-02-01 | 2025-03-18 |
| OM 85 to Prevent Respiratory Infections in Older At Risk Patients Bacterial Lysate, Placebo - Respiratory Tract Infections (RTI) | Phase 4 | Active not recruiting | Fondazione Policlinico Universitario Campus Bio-Medico | 360 | 2024-12-19 | 2025-09-17 |
| The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome OM-89 [Uro-Vaxom® Capsule], OM-89 Placebo [Uro-Vaxom® Capsule Placebo] - Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Prostatitis | Phase 4 | Unknown | AJU Pharm Co., Ltd. | 332 | 2023-12-20 | 2024-04-04 |
| OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness OM-85, Placebo - Respiratory Tract Infections, Wheezing Lower Respiratory Illness | Phase 4 | Completed | OM Pharma SA | 525 | 2022-12-12 | 2026-09-25 |
Respiratory Tract Infections (3) · Prostatitis (1)
Broncho-Vaxom (2) · OM 89 (1)
Italy (3) · Germany (1) · Hungary (1) · Poland (1) · South Korea (1) · Switzerland (1) · United Kingdom (1)